How is neonatal hypoglycemia defined and what is the initial treatment approach?

How is neonatal hypoglycemia defined and what is the initial treatment approach?

• A. Plasma glucose below 60 mg/dL in term infants; treat with oral glucose gel.
• B. Plasma glucose below threshold (e.g., <40 mg/dL term, <50 mg/dL preterm); treat with IV dextrose bolus (2-4 mL/kg of 10% dextrose), followed by slower infusion; monitor and investigate etiologies.
• C. Any glucose below 70 mg/dL requires phototherapy.
• D. Hypoglycemia defined by symptoms only; treatment with diuretics.

Answer: (B)

Neonatal hypoglycemia is defined by specific plasma glucose thresholds that vary with gestational age. In term infants, a plasma glucose level below about 40 mg/dL is considered hypoglycemia, while in preterm babies a lower threshold (around 50 mg/dL) is used because their brains are more vulnerable and their regulation is less robust. The aim is to correct the low glucose quickly to prevent neuroglycopenia, and to start looking for underlying causes such as maternal diabetes, intrauterine stress, prematurity, small for gestational age, or infection. Initial treatment focuses on rapidly raising blood glucose with an IV dextrose bolus, then transitioning to a maintenance infusion. A typical bolus is 2 mL/kg of 10% dextrose (some protocols allow 2–4 mL/kg). After the bolus, begin a slower dextrose infusion and adjust the rate to keep glucose above a safe level (usually >45 mg/dL in term infants), with glucose checks every hour or so. Alongside treatment, investigate possible etiologies to address the underlying cause and prevent recurrence.

Neonatal hypoglycemia is defined by specific plasma glucose thresholds that vary with gestational age. In term infants, a plasma glucose level below about 40 mg/dL is considered hypoglycemia, while in preterm babies a lower threshold (around 50 mg/dL) is used because their brains are more vulnerable and their regulation is less robust. The aim is to correct the low glucose quickly to prevent neuroglycopenia, and to start looking for underlying causes such as maternal diabetes, intrauterine stress, prematurity, small for gestational age, or infection.

Initial treatment focuses on rapidly raising blood glucose with an IV dextrose bolus, then transitioning to a maintenance infusion. A typical bolus is 2 mL/kg of 10% dextrose (some protocols allow 2–4 mL/kg). After the bolus, begin a slower dextrose infusion and adjust the rate to keep glucose above a safe level (usually >45 mg/dL in term infants), with glucose checks every hour or so. Alongside treatment, investigate possible etiologies to address the underlying cause and prevent recurrence.